top of page

A computational biologist and assistant professor at Philadelphia’s Wistar Institute on positives and potential negatives of AI’s emergence to the forefront of life sciences

  • blonca9
  • May 6, 2024
  • 1 min read

An early adopter and researcher of AI, Noam Auslander shares her opinion of the benefits of AI but also guardrails that should be considered to protect patient data.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTVHQ

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent logo_tagline.png

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page